Background illustration for clinical trials search

Paid Clinical Trials Arlington

Discover 1,944 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Impact of Foot Orthoses on Gait in Individuals With Ataxia

for
Ataxia
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT07720700

Recruiting
Active & Responsive

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

for
Lymphoma, Non-Hodgkin, B-cell Lymphoma,
Location: Dallas TX, Houston TX, Kansas City KS, Nashville TN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07101328

Phase 1, Recruiting
Active & Responsive

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria

for
Phenylketonuria
Location: Dallas TX, Indianapolis IN, Pittsburgh PA
Sponsor: Agios Pharmaceuticals, Inc.

Sex: All

Age: 18 - 69

Code: NCT07241234

Phase 1, Recruiting
Active & Responsive

Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.

for
Hereditary Spastic Paraplegia Type 50
Location: Dallas TX
Sponsor: Elpida Therapeutics SPC

Sex: All

Age: 0 - 6

Code: NCT06692712

Phase 3, Recruiting
Active & Responsive

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

for
Cystic Fibrosis
Location: Dallas TX, Kansas City KS, Birmingham AL, Pensacola FL,
Sponsor: Boston Children's Hospital

Sex: All

Age: 6+

Code: NCT06683092

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

for
LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\),
Location: Dallas TX, St Louis MO, Iowa City IA, Chicago IL,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 0 - 5

Code: NCT06503367

Recruiting
Active & Responsive

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Location: Dallas TX, Oklahoma City OK, Houston TX, Jackson MS,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT01915511

Recruiting
Active & Responsive

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

for
Single Ventricle Heart Disease
Location: Dallas TX, Houston TX, Little Rock AR, Kansas City MO,
Sponsor: Mezzion Pharma Co. Ltd

Sex: All

Age: 12 - 18

Code: NCT05918211

Phase 3, Recruiting
Active & Responsive

Concussion Health Improvement Program

for
Concussion, Brain, Brain Injury Traumatic Mild
Location: Dallas TX
Sponsor: Seattle Children's Hospital

Sex: All

Age: 11 - 18

Code: NCT06036147

Recruiting
Active & Responsive

Danon Disease Natural History Study

for
Danon Disease
Location: Dallas TX, Houston TX, St Louis MO, Aurora CO,
Sponsor: Rocket Pharmaceuticals Inc.

Sex: All

Age: 8+

Code: NCT06214507

Recruiting
Active & Responsive

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

for
Prostate Cancer, Prostatic Neoplasms
Location: Dallas TX, Houston TX, Memphis TN, Albuquerque NM,
Sponsor: Merck Sharp & Dohme LLC

Sex: Male

Age: 18+

Code: NCT06925737

Phase 3, Recruiting
Active & Responsive

A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

for
HIV-1-infection
Location: Dallas TX, Longview TX, Austin TX, Houston TX,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07645287

Phase 2, Recruiting
Active & Responsive

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: Dallas TX, Birmingham AL, Nashville TN, Aurora CO,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05722418

Phase 1, Recruiting
Active & Responsive

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Dallas TX, Savannah GA, Pittsburgh PA, London, Toronto,
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT02468024

Phase 3, Recruiting
Active & Responsive

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

for
Surgery-Complications, Anesthesia Complication,
Location: Dallas TX, Houston TX, Little Rock AR, St Louis MO,
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT05991453

Recruiting
Active & Responsive

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

for
Diabetic Nephropathies, Kidney Failure, Chronic,
Location: Dallas TX, St Louis MO, Aurora CO, Chicago IL,
Sponsor: Alessandro Doria

Sex: All

Age: 18 - 70+

Code: NCT06217302

Phase 3, Recruiting
Active & Responsive

STRIVE Post-Market Registry Study

for
Emphysema
Location: Dallas TX, Shreveport LA, Houston TX, Gulfport MS,
Sponsor: Olympus Corporation of the Americas

Sex: All

Age: 18+

Code: NCT04302272

Recruiting
Active & Responsive

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

for
Treatment Resistant Depression
Location: Dallas TX, Austin TX, Houston TX, Flowood MS,
Sponsor: LivaNova

Sex: All

Age: 18+

Code: NCT03887715

Recruiting
Active & Responsive

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

for
Treatment Resistant Depression
Location: Dallas TX, Austin TX, Houston TX, St Louis MO,
Sponsor: Abbott Medical Devices

Sex: All

Age: 22 - 70

Code: NCT06423430

Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Dallas TX, Temple TX, Austin TX, Houston TX, Wichita KS,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase 3, Recruiting